1. Home
  2. HLIT vs ANAB Comparison

HLIT vs ANAB Comparison

Compare HLIT & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmonic Inc.

HLIT

Harmonic Inc.

HOLD

Current Price

$11.78

Market Cap

1.5B

Sector

Technology

ML Signal

HOLD

Logo AnaptysBio Inc.

ANAB

AnaptysBio Inc.

N/A

Current Price

$56.80

Market Cap

1.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HLIT
ANAB
Founded
1988
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
HLIT
ANAB
Price
$11.78
$56.80
Analyst Decision
Buy
Buy
Analyst Count
4
12
Target Price
$14.67
$71.67
AVG Volume (30 Days)
1.5M
377.0K
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
91.02
EPS
0.05
N/A
Revenue
N/A
$234,603,000.00
Revenue This Year
$42.73
N/A
Revenue Next Year
$18.36
$52.14
P/E Ratio
$235.60
N/A
Revenue Growth
N/A
157.01
52 Week Low
$8.47
$17.11
52 Week High
$17.68
$73.30

Technical Indicators

Market Signals
Indicator
HLIT
ANAB
Relative Strength Index (RSI) 42.45 49.46
Support Level $11.38 $53.46
Resistance Level $12.48 $57.70
Average True Range (ATR) 0.39 2.33
MACD -0.06 -0.15
Stochastic Oscillator 5.83 38.76

Price Performance

Historical Comparison
HLIT
ANAB

About HLIT Harmonic Inc.

Harmonic Inc engaged in broadband access solutions that enable broadband operators to more efficiently and effectively deploy high-speed internet for data, voice, and video services for their customers and versatile and high-performance video delivery software, products, system solutions and services that enable its customers to efficiently create, prepare, store, playout and deliver a full range of high-quality broadcast and streaming video services to consumer devices, including televisions, personal computers, laptops, tablets, and smartphones. It has two segments, Broadband which provides broadband access solutions and related services, and Others; and Video business provides video processing and production and playout solutions and services, and Others.

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Share on Social Networks: